ing a claim. In addition, there is no compensation 
for attorney fees, which makes it extremely difficult 
for vaccine-injured Americans to find counsel willing 
to represent them. 
(14) Since the advent of the COVID–19 vac-
cines and as of February 1, 2022, there have been 
NO compensation awards issued by the CICP for 
COVID–19 vaccine injury claims. 
(15) The United States constitutional structure 
demands measures of accountability for government 
actions that infringe individual liberties and could 
cause harm. If Congress or the courts fail to nullify, 
overturn, or invalidate unnecessary, authoritarian, 
and overreaching COVID–19 vaccine mandates that 
threaten the loss of employment for noncompliance, 
Americans oppressed by such mandates and coerced 
into vaccination should be able to hold governments 
accountable. They should have full and unfettered 
access to legal recourses for any adverse health ef-
fects or injuries sustained from such COVID–19 
vaccine mandates. This should include the right to 
bring civil actions for declaratory or injunctive relief, 
or monetary compensatory damages, including eco-
nomic and noneconomic damages, against Federal, 
VerDate Sep 11 2014 
22:02 Mar 01, 2022
Jkt 029200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H6811.IH
H6811
kjohnson on DSK79L0C42PROD with BILLS
State, and local government entities that impose 
such mandates. 
(16) It is well-established that Congress’ power 
under article I, section 8, clause 1 of the Constitu-
tion, also known as the Spending Clause, includes 
the power to require the States to abide by certain 
conditions in exchange for receiving Federal finan-
cial assistance. The Supreme Court has explained 
that one such lawful condition may be States volun-
tarily waiving their sovereign immunity from suit 
(under the Eleventh Amendment to the Constitution 
or otherwise). South Dakota v. Dole (483 U.S. 203 
(1987)); College Savings Bank v. Florida Prepaid 
Postsecondary Education Expense Board (527 U.S. 
666 (1999)). 
(17) Such a conditional waiver does not coerce 
a State. The Supreme Court has explicitly recog-
nized that when Congress expresses a funding condi-
tion ‘‘unambiguously’’, a State’s acceptance of Fed-
eral funds constitutes a knowing agreement to a 
congressionally imposed condition on the funds. 
Pennhurst State School & Hospital v. Halderman 
(451 U.S. 1, 17 (1981)). Accordingly, while Con-
gress may not compel States to waive their sovereign 
VerDate Sep 11 2014 
22:02 Mar 01, 2022
Jkt 029200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H6811.IH
H6811
kjohnson on DSK79L0C42PROD with BILLS
immunity, a voluntary State waiver is wholly permis-
sible. Alden v. Maine (527 U.S. 706 (1999)). 
(18) This Act protects Americans’ constitu-
tional medical rights by ensuring that individuals 
subject to a scientifically tenuous ‘‘Hobson’s Choice’’ 
of employment-threatening COVID–19 vaccine man-
date, where they feel forced into vaccination against 
their will, are able to seek equitable and appropriate 
legal remedies for any COVID–19 vaccine injuries, 
remedies that are extremely limited or disallowed 
under current law. 
(19) This Act further protects Americans’ con-
stitutional medical rights by holding Federal, State, 
and local governments accountable for unnecessary, 
irrational, 
overreaching, 
and 
liberty-infringing 
COVID–19 vaccine mandates, when many other sci-
entifically proven, and less liberty-intrusive, tools 
exist for mitigating the effects of and protecting 
against COVID–19. 
SEC. 3. DEFINITIONS. 
In this Act: 
(1) AGGRIEVED INDIVIDUAL.—The term ‘‘ag-
grieved individual’’ includes— 
(A) an individual who received or is re-
quired to receive a COVID–19 vaccine as a re-
VerDate Sep 11 2014 
22:02 Mar 01, 2022
Jkt 029200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H6811.IH
H6811
kjohnson on DSK79L0C42PROD with BILLS
sult of Executive Order 14042 or 14043 to pre-
vent the termination, or any other adverse con-
sequence, of the employment of the individual 
with a Federal agency, or as a condition of new 
employment; 
(B) an individual who received a COVID– 
19 vaccine as a result of a Federal agency re-
quirement (or is required to do so by the indi-
vidual’s employer acting pursuant to a Federal 
agency requirement) as a condition of new or 
continued employment, including a COVID–19 
vaccine requirement resulting from— 
(i) the rule titled ‘‘COVID–19 Vac-
cination and Testing; Emergency Tem-
porary Standard’’ published on November 
5, 2021 (86 Fed. Reg. 61402 et seq.); or 
(ii) the rule titled ‘‘Medicare and 
Medicaid Programs; Omnibus COVID–19 
Health Care Staff Vaccination’’ published 
November 5, 2021 (86 Fed. Reg. 61555 et 
seq.); and 
(C) an individual who received or is re-
quired to receive a COVID–19 vaccine as a re-
sult of a State or local governmental require-
ment, or by their employer that is acting pursu-
VerDate Sep 11 2014 
22:02 Mar 01, 2022
Jkt 029200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H6811.IH
H6811
kjohnson on DSK79L0C42PROD with BILLS